Is Cytocarb vesicant/cardio-toxic/ anthracycline?
Nov 3, 2023
Is Cytocarb vesicant/cardio-toxic/ anthracycline?
Cytocarb does not pose any risk of cardiotoxicity nor does it belong to the class of anthracyclines which are known to have potential cardiovascular side effects Additionally it is not a vesicant meaning it does not cause significant tissue damage if it leaks into the surrounding tissues during administration Cytocarb is a medication that is commonly used in the treatment of various types of cancer It belongs to a different class of drugs known as antimetabolites specifically a group called pyrimidine antagonists These drugs work by interfering with the synthesis of DNA and RNA ultimately preventing cancer cells from growing and dividing Unlike anthracyclines which can cause damage to the heart muscle leading to potential heart problems Cytocarb has a different mechanism of action and does not carry the same cardiovascular risks This makes it a safer option for patients who may have preexisting heart conditions or who are at an increased risk of cardiovascular complications Furthermore unlike certain chemotherapy drugs that are considered vesicants Cytocarb is not known to cause severe tissue damage if it accidentally leaks out of the vein during administration This reduces the potential for complications and ensures a safer administration process for healthcare professionals and patients alike Overall Cytocarb is a welltolerated and safe medication for the treatment of cancer without the cardiotoxic anthracycline or vesicant properties commonly associated with other chemotherapy agents
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹2385₹2650
₹2362₹2624
₹2318₹2576
₹2520₹2800
₹4005₹4450
₹2430₹2700
₹2435₹2705
₹2527₹2808
₹2430₹2700
₹1875₹2083